tanshinone has been researched along with Granulocytic Leukemia, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, R; Ge, Y; Lai, M; Sun, S; Zhu, L | 1 |
| Chu, T; Fu, HM; Jia, YQ; Li, H; Mao, SJ; Meng, WT; Shi, HY; Song, XR; Zhang, Q | 1 |
| Jeong, SJ; Jung, JH; Kim, JH; Kim, SH; Lee, HJ; Lee, MH; Sohn, EJ; Yun, SM | 1 |
3 other study(ies) available for tanshinone and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Tanshinone I inhibited growth of human chronic myeloid leukemia cells via JNK/ERK mediated apoptotic pathways.
Topics: Abietanes; Apoptosis; Cell Line, Tumor; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2021 |
Growth-inhibitory and apoptosis-inducing effects of tanshinones on hematological malignancy cells and their structure-activity relationship.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Inhibitory Concentration 50; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Microscopy, Fluorescence; Phenanthrenes; Structure-Activity Relationship; Time Factors | 2012 |
Activation of c-Jun N-terminal kinase mediates tanshinone IIA-induced apoptosis in KBM-5 chronic myeloid leukemia cells.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cells, Cultured; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytes, Mononuclear; Membrane Potential, Mitochondrial; p38 Mitogen-Activated Protein Kinases | 2013 |